Blood Glucose SOP
Blood Glucose SOP
Date Approved:
February 2015
Date Implemented:
February 2015
Date of Review:
February 2016
Version: 1.3
Document Control
Version:
1.3
Title:
SOP Category:
Clinical / Operations
Date Approved:
February 2015
Date Implemented:
February 2015
Supersedes:
None
Date of Review:
February 2016
SOP Owner:
SOP Approval:
Supporting Documents
Document Name:
Version
Date
Author
Comment
1.0
November 2012
Paramedic Advisor
SOP Developed
1.1
January 2013
Paramedic Advisor
Change of Product
1.2
February 2014
Paramedic Advisor
Supplier Amendment
1.3
February 2015
Paramedic Advisor
Page 2
1. Introduction
St. John Cymru Wales (hereafter referred to as St John) acknowledges the benefit of
blood glucose monitoring (BM) by approved, appropriately trained members but is also
aware of the potential Health and Safety and Patient Safety impacts of blood glucose
monitoring, identified by the Medicines and Healthcare Regulatory Agency (MHRA),
and will seek to limit these through the use of robust policies and procedures.
2. Purpose
2.1.
St John requires that all parts of its activities and operations have an
understanding of their responsibilities for BM Monitoring. The purpose of this
procedure is to:
a)
b)
c)
d)
3. Scope
3.1.
This procedure will apply to all personnel who have achieved the Enhanced
First Aider or Patient or Emergency Transport Attendant qualification. Due to
the potential for error and adverse events, BM monitoring will be restricted to
the aforementioned skill levels and a thorough training and assessment
package will be in place with annual recertification. Healthcare Professionals
(HCPs) are reminded that national clinical guidelines should be followed at all
times and that they are accountable to their own professional registering
body.
4. Responsibilities
4.1.
Page 3
Page 4
5.2.
Page 5
As per MHRA guidelines, the information below highlights the only Blood
Glucose Monitoring Equipment for use by St John personnel. No personal
devices are to be used at any time. All of the equipment listed is required.
a) Approved Blood Glucose Machine:
Model :
Accu-Chek Aviva
Supplier:
Notes:
Supplier:
Notes:
Supplier:
Notes:
Page 6
After ensuring the blood glucose machine has been appropriately calibrated,
the following procedure is carried out
1. Explain and ask the patient for their consent to carry out the procedure
2. Adopt appropriate Infection Control methods
3. Prepare equipment and ensure the glucose monitor is fully calibrated
4. Clean the tip of the selected finger with a cleansing wipe or saline & swab
and allow to dry
5. Prepare the test strip, ensuring that it is still in date and load into glucose
monitor
6. Prick the side of the finger with the lancet and squeeze the finger to draw
blood
7. Dispose of the lancet into a Sharps Box
8. Place the drop of blood onto the test strip so that the strip is covered
9. Give the patient a gauze swab and advise them to apply pressure to stop
bleeding
10. Record the reading from the glucose monitor display
11. Dispose of the test strip into a clinical waste bag
12. Remove gloves and wash hands
All blood glucose monitoring equipment should be calibrated at least every six
months or if the integrity of the test strips are suspect and when the result is
not in keeping with the clinical condition of the patient.
8.2.
For the procedure of calibrating the blood glucose machine, refer to the
manufacturers guideline.
Page 7
9. Training
9.1.
All personnel undertaking the EFA, PTA and ETA will receive training in how
to correctly carry out the blood glucose monitoring procedure. All personnel
already holding this qualification will receive an additional, mandatory training
course.
9.2.
Monitored training will take place in the form of formative assessments and
completion of the OSCE Record Sheet (Appendix I).
9.3.
9.4.
9.5.
9.6.
During training, candidates will practice the skill of obtaining a blood sample
utilising their own capillary blood or if verbal consent is given by another
individual; a sample can be obtained from them.
9.7.
All candidates reserve the right to decline carrying out the procedure or
offering a blood sample and therefore can alternatively verbalise the
procedure instead.
9.8.
Page 8
12. References
Lancing Devices used in Nursing Homes and Care Homes (2006), Medical Device
Alert, Medicine and Healthcare Regulatory Agency, London
National Institute for Clinical Excellence (2004) Type 1 diabetes: diagnosis and
management of type 1 diabetes in children, young people and adults, National
Institute for Clinical Excellence, London
Point of Care Testing Blood Glucose Meter Advice for Health Care Professionals
(2005) Medicine and Healthcare Regulatory Agency, London
Page 9
Appendix I
Trainer Initial
1
Trainer Initial
Page 10